Caligan Partners Lp Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Caligan Partners Lp disclosed 25 stock positions valued at approximately $2.07B as of quarter-end June 30, 2026. The largest holdings include LIQUIDIA CORPORATION, REVOLUTION MEDICINES INC, and ABIVAX SA.
- Report Period
- June 30, 2026
- No. of Stocks
- 25
- Portfolio Value
- $2.07B
Holdings by Sector
Caligan Partners Lp Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| LIQUIDIA CORPORATION | LQDA | Healthcare | 31.23% | 8,118,892 | - | - | $647,319,259 |
| REVOLUTION MEDICINES INC | RVMD | Healthcare | 17.73% | 1,961,795 | +308,987 | +18.69% | $367,404,968 |
| ABIVAX SA | ABVX | Healthcare | 10.02% | 1,557,924 | +96,000 | +6.57% | $207,608,952 |
| VAXCYTE INC | PCVX | Healthcare | 6.14% | 2,188,636 | +127,917 | +6.21% | $127,225,411 |
| EXELIXIS INC | EXEL | Healthcare | 4.08% | 1,553,262 | - | - | $84,512,985 |
| TANGO THERAPEUTICS INC | TNGX | Healthcare | 3.77% | 2,500,103 | +91,305 | +3.79% | $78,153,220 |
| AVALO THERAPEUTICS INC | AVTX | Healthcare | 2.82% | 3,163,866 | +1,528,843 | +93.51% | $58,468,244 |
| XENON PHARMACEUTICALS INC | XENE | Healthcare | 2.59% | 889,944 | -503,083 | -36.11% | $53,717,020 |
| ADMA BIOLOGICS INC | ADMA | Healthcare | 2.31% | 5,725,007 | +968,496 | +20.36% | $47,918,309 |
| LB PHARMACEUTICALS INC | LBRX | Other | 2.25% | 1,438,070 | - | - | $46,672,562 |
| IMMUNOCORE HLDGS PLC | IMCR | Healthcare | 2.12% | 1,381,317 | +1,381,317 | +100.00% | $43,856,815 |
| VIRIDIAN THERAPEUTICS INC | VRDN | Healthcare | 1.94% | 2,193,981 | +2,193,981 | +100.00% | $40,303,431 |
| VOR BIOPHARMA INC | VOR | Other | 1.71% | 1,925,066 | - | - | $35,440,465 |
| SAB BIOTHERAPEUTICS INC | SABS | Healthcare | 1.50% | 7,967,207 | - | - | $31,072,107 |
| INVENTIVA SA | IVA | Other | 1.49% | 8,163,191 | +3,188,285 | +64.09% | $30,856,862 |
| AURA BIOSCIENCES INC | AURA | Healthcare | 1.47% | 4,298,248 | +4,068,384 | +1769.91% | $30,517,561 |
| TYRA BIOSCIENCES INC | TYRA | Healthcare | 1.24% | 806,986 | -469,982 | -36.80% | $25,775,133 |
| OPUS GENETICS INC | OCUP | Other | 1.21% | 6,077,084 | +2,056 | +0.03% | $24,976,815 |
| ANIKA THERAPEUTICS INC | ANIK | Healthcare | 1.01% | 1,435,130 | - | - | $20,995,952 |
| SAGIMET BIOSCIENCES INC | SGMT | Healthcare | 0.93% | 2,500,000 | +2,500,000 | +100.00% | $19,325,000 |
| ARTIVA BIOTHERAPEUTICS INC | ARTV | Other | 0.81% | 1,736,111 | +1,736,111 | +100.00% | $16,840,277 |
| FAETH THERAPEUTICS INC | FTH | Other | 0.76% | 629,467 | +503,465 | +399.57% | $15,736,675 |
| MBX BIOSCIENCES INC | MBX | Other | 0.53% | 200,000 | -648,590 | -76.43% | $11,040,000 |
| VERRICA PHARMACEUTICALS INC | VRCA | Other | 0.27% | 923,910 | - | - | $5,654,329 |
| CELLECTAR BIOSCIENCES INC | CLRB | Other | 0.06% | 469,998 | +469,998 | +100.00% | $1,306,594 |
Showing 25 of 25 holdings in the latest reporting period.
Caligan Partners Lp Options Holdings in Q2 2026
Showing 3 of 3 options positions in the latest reporting period.
Notional value represents the total exposure of the options position.